天津药业研究院

Tianjin Pharmaceutical Research Institute is the core research and development arm of Tianjin Pharmaceutical Group (also known as Jinyao Group). Established in 2002, the institute focuses on the research, development, and industrialization of steroid hormone drugs, amino acids, and advanced formulations. It operates state-of-the-art R&D platforms, including the Steroid Innovative Drug Research Platform and the Chemical Drug Innovation R&D Platform. The institute supports the parent group's dominant position in the corticosteroids market and collaborates with academic institutions to advance peptide drug discovery and other therapeutic modalities.